Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation.


Kayaoglu B., Kasap N., Yilmaz N. S. , Charbonnier L. M. , Geckin B., Akcay A., ...Daha Fazla

Journal of clinical immunology, 2021 (SCI Expanded İndekslerine Giren Dergi) identifier